Correlation Between China Times and Foresee Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both China Times and Foresee Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Times and Foresee Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Times Publishing and Foresee Pharmaceuticals Co, you can compare the effects of market volatilities on China Times and Foresee Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Times with a short position of Foresee Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Times and Foresee Pharmaceuticals.
Diversification Opportunities for China Times and Foresee Pharmaceuticals
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between China and Foresee is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding China Times Publishing and Foresee Pharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foresee Pharmaceuticals and China Times is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Times Publishing are associated (or correlated) with Foresee Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foresee Pharmaceuticals has no effect on the direction of China Times i.e., China Times and Foresee Pharmaceuticals go up and down completely randomly.
Pair Corralation between China Times and Foresee Pharmaceuticals
Assuming the 90 days trading horizon China Times Publishing is expected to generate 1.61 times more return on investment than Foresee Pharmaceuticals. However, China Times is 1.61 times more volatile than Foresee Pharmaceuticals Co. It trades about 0.04 of its potential returns per unit of risk. Foresee Pharmaceuticals Co is currently generating about 0.02 per unit of risk. If you would invest 1,800 in China Times Publishing on September 3, 2024 and sell it today you would earn a total of 30.00 from holding China Times Publishing or generate 1.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
China Times Publishing vs. Foresee Pharmaceuticals Co
Performance |
Timeline |
China Times Publishing |
Foresee Pharmaceuticals |
China Times and Foresee Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with China Times and Foresee Pharmaceuticals
The main advantage of trading using opposite China Times and Foresee Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Times position performs unexpectedly, Foresee Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foresee Pharmaceuticals will offset losses from the drop in Foresee Pharmaceuticals' long position.China Times vs. Fubon MSCI Taiwan | China Times vs. YuantaP shares Taiwan Top | China Times vs. YuantaP shares Taiwan Electronics | China Times vs. YuantaP shares Taiwan Mid Cap |
Foresee Pharmaceuticals vs. GeneFerm Biotechnology Co | Foresee Pharmaceuticals vs. Ruentex Development Co | Foresee Pharmaceuticals vs. Symtek Automation Asia | Foresee Pharmaceuticals vs. CTCI Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |